BR9106752A - Oligonucleotideo ou analogo de oligonucleotideo,processo para tratamento de uma infeccao por candida e processo para a modulacao da atividade de candida - Google Patents

Oligonucleotideo ou analogo de oligonucleotideo,processo para tratamento de uma infeccao por candida e processo para a modulacao da atividade de candida

Info

Publication number
BR9106752A
BR9106752A BR919106752A BR9106752A BR9106752A BR 9106752 A BR9106752 A BR 9106752A BR 919106752 A BR919106752 A BR 919106752A BR 9106752 A BR9106752 A BR 9106752A BR 9106752 A BR9106752 A BR 9106752A
Authority
BR
Brazil
Prior art keywords
candidate
oligonucleotideo
infection
treating
modulating
Prior art date
Application number
BR919106752A
Other languages
English (en)
Portuguese (pt)
Inventor
Glenn D Hoke
David J Ecker
Original Assignee
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc
Publication of BR9106752A publication Critical patent/BR9106752A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
BR919106752A 1990-08-16 1991-08-15 Oligonucleotideo ou analogo de oligonucleotideo,processo para tratamento de uma infeccao por candida e processo para a modulacao da atividade de candida BR9106752A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56867290A 1990-08-16 1990-08-16
PCT/US1991/005802 WO1992003455A1 (fr) 1990-08-16 1991-08-15 INHIBITION DE $i(CANDIDA)

Publications (1)

Publication Number Publication Date
BR9106752A true BR9106752A (pt) 1993-08-17

Family

ID=24272249

Family Applications (1)

Application Number Title Priority Date Filing Date
BR919106752A BR9106752A (pt) 1990-08-16 1991-08-15 Oligonucleotideo ou analogo de oligonucleotideo,processo para tratamento de uma infeccao por candida e processo para a modulacao da atividade de candida

Country Status (6)

Country Link
EP (1) EP0652888A1 (fr)
JP (1) JPH0779704B2 (fr)
AU (1) AU649734B2 (fr)
BR (1) BR9106752A (fr)
CA (1) CA2089665A1 (fr)
WO (1) WO1992003455A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020055101A1 (en) 1995-09-11 2002-05-09 Michel G. Bergeron Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
DE19654946A1 (de) * 1996-10-22 1998-05-07 Univ Eberhard Karls Verfahren zum Nachweis von resistenten Pilzzellen in klinischem Material
DE19643486C1 (de) * 1996-10-22 1998-12-03 Univ Eberhard Karls Nachweis von resistenten Pilzzellen in klinischem Material
FR2755145B1 (fr) * 1996-10-28 1999-01-15 Gervais Danone Co Procede de mise en evidence de contaminants microbiologiques vivants dans un echantillon de produit a usage alimentaire
US20030049636A1 (en) 1999-05-03 2003-03-13 Bergeron Michel G. Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
US20100267012A1 (en) 1997-11-04 2010-10-21 Bergeron Michel G Highly conserved genes and their use to generate probes and primers for detection of microorganisms
US6096511A (en) * 1997-06-10 2000-08-01 Merck & Co., Inc. Protein elongation factor 2 as a target for antifungal and antiparasitic agents
WO1998057176A1 (fr) * 1997-06-10 1998-12-17 Merck & Co., Inc. Proteine facteur d'elongation 2 en tant que cible pour des antifongiques et des antiparasitaires
GB9719044D0 (en) * 1997-09-08 1997-11-12 Inst Of Ophthalmology Assay
EP1246935B1 (fr) 1999-09-28 2013-08-14 Geneohm Sciences Canada Inc. Genes a fort pouvoir de conservation et leur utilisation pour produire des sondes d'acide nucleique specifiques a l'espece, specifiques au gene, specifiques a la famille, specifiques au groupe et universelles et des sondes d'amplification, en vue de detecter et d'identifier rapidement des micro-orga
KR100448877B1 (ko) * 2002-08-19 2004-09-18 한국전력공사 전기화학적 산화공정을 이용한 탈황폐수의 씨오디 성분저감장치
US20040203006A1 (en) * 2003-04-11 2004-10-14 Cytokinetics, Inc. Novel beta-tubulin protein of Candida glabrata and methods for its use
CN113508176A (zh) * 2019-02-28 2021-10-15 米尼翁大学 用于控制白色念珠菌感染的反义寡聚物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU659482B2 (en) * 1991-06-28 1995-05-18 Massachusetts Institute Of Technology Localized oligonucleotide therapy
NZ244820A (en) * 1991-10-25 1994-01-26 Isis Pharmaceuticals Inc Oligonucleotide inhibitor of epstein-barr virus.
GB9125891D0 (en) * 1991-12-05 1992-02-05 Inst Of Cancer The Research Antiviral agent

Also Published As

Publication number Publication date
WO1992003455A1 (fr) 1992-03-05
JPH06501844A (ja) 1994-03-03
AU8635591A (en) 1992-03-17
EP0652888A1 (fr) 1995-05-17
AU649734B2 (en) 1994-06-02
EP0652888A4 (fr) 1993-09-23
CA2089665A1 (fr) 1992-02-17
JPH0779704B2 (ja) 1995-08-30

Similar Documents

Publication Publication Date Title
BR9106751A (pt) Oligonucleotideo ou analogo de nucleotideo e processo para modulacao da atividade de uma infeccao por citomegalovirus
BR9106752A (pt) Oligonucleotideo ou analogo de oligonucleotideo,processo para tratamento de uma infeccao por candida e processo para a modulacao da atividade de candida
BR9206070A (pt) Processo para tratar vidro de fluoroaluminossilicato, vidro de fluoroaluminossilicato tratado e alcoxissilanos poliméricos etilenicamente insaturados.
BR8805440A (pt) Processo para a fabricacao de 1,1,1-trifluorodicloroetano e/ou 1,1,1,2-tetrafluorocloroetano por fluoracao de um tetrahaloetileno
DE69022163D1 (de) Steriles erzeugnis und verfahren zur sterilisierung und zusammenbau dieses erzeugnisses.
BR8804098A (pt) Compostos,composicoes e processo para reducao da fitotoxidez de plantas de cultura
BR9607083A (pt) Processos para preparar sulfeto ciclico de 1,1-ciclo-propano-dimetanol 1-hidróxi-metil-cciclo-propano-acetonitrila e ácido 1-tío-metíl-ciclo propano-acético
DE69006266D1 (de) Krackkatalysator und Verfahren.
BR9609084A (pt) Um processo para o tratamento de madeira com bactérias
DE122011100046I1 (de) In vitro kulturprozess fur verschiedene stadien von gewebeparasiten.
BR9204924A (pt) Associacao agroquimica,composicao agroquimica e processo de tratamento de plantas
IT1240486B (it) Procedimento di ammollo enzimatico per pelli e pellami.
BR9100858A (pt) Metodo de tratar papelao e similares,folha de papelao e recipiente fabricado de papelao
BR8904960A (pt) Composicao catalisadora de vanadio,e processo de polimerizacao
BR9101129A (pt) Processo e forno de tratamento de rejeito
DE69019950D1 (de) Träger zur kultivierung von mikroorganismen, davon hergestellter träger zur kontrolle von parasitenbefall und verfahren zur parasitenbekämpfung.
DE59005066D1 (de) Verfahren und Vorrichtung zum Keimfreimachen, Desinfizieren und/oder Trocknen.
DE69012304D1 (de) Einrichtung zur Augenbehandlung.
PT93510A (pt) Recipiente e processo de esterilizacao
DE69022813D1 (de) Abfallbehandlung.
BR9007874A (pt) Processo para o tratamento posterior de tenso-ativos anfoteros ou zwitterionicos
PT88254A (pt) Processo para a preparacao de derivados de eritromicina a modificada em c.12
DE68907569D1 (de) Mittel zur behandlung oder vorbeugung von aids.
BR9002705A (pt) Processo de polimerizacao,produto e composicao
BR9007285A (pt) Processo para o tratamento biologico de aguas servidas com o auxilio de microorganismos

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal
B15K Others concerning applications: alteration of classification

Ipc: C12N 15/113 (2010.01), C07K 14/39 (2006.0